Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) and Profusa (NASDAQ:PFSA – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, earnings, risk and institutional ownership.
Profitability
This table compares Kewaunee Scientific and Profusa’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kewaunee Scientific | 2.97% | 11.75% | 4.78% |
| Profusa | N/A | N/A | -1,731.09% |
Valuation and Earnings
This table compares Kewaunee Scientific and Profusa”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Kewaunee Scientific | $282.00 million | 0.36 | $9.62 million | $2.76 | 12.99 |
| Profusa | $100,000.00 | 15.09 | -$35.82 million | ($5,619.96) | -0.00 |
Kewaunee Scientific has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 9.8% of Profusa shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by company insiders. Comparatively, 15.0% of Profusa shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Kewaunee Scientific has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Profusa has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings for Kewaunee Scientific and Profusa, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kewaunee Scientific | 0 | 1 | 0 | 0 | 2.00 |
| Profusa | 1 | 0 | 0 | 0 | 1.00 |
Summary
Kewaunee Scientific beats Profusa on 10 of the 12 factors compared between the two stocks.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
About Profusa
NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
